Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy

Citations

WEB OF SCIENCE

1
Citations

SCOPUS

1

초록

Lymphadenopathy after coronavirus disease 2019 (COVID-19) vaccination is a common side effect that usually resolves within several days to weeks, and only observation is recommended. However, for prolonged lymphadenopathy, other possibilities, including malignancy or other lymphoproliferative diseases, may be considered. Herein, we report the case of a 66-year-old woman who experienced prolonged ipsilateral supraclavicular lymph node enlargement after the second dose of the ChAdOx1 (Oxford-AstraZeneca) COVID-19 vaccine, which was eventually diagnosed as extrapulmonary tuberculosis.

키워드

lymphadenopathyCOVID-19vaccinationtuberculosis
제목
Manifestation of Subclinical Extrapulmonary Tuberculosis after COVID-19 Vaccination as Supraclavicular Lymphadenopathy
저자
Cha, Han GyuKim, Dong GyuChoi, Joon Ho
DOI
10.3390/vaccines10060964
발행일
2022-06
유형
Article
저널명
Vaccines
10
6
페이지
1 ~ 6